Directing alternative splicing to conquer disease
In Memory of Our Co-Founder Dr. Melanie Tallent
NIH Grant Awarded ($670 K) to further Development of Drug to Treat Dravet Syndrome
NIH Grant Awarded ($340K) for Initial Drug Development of a Novel Alzheimer’s Disease Treatment.
AMPA GluA1-flip targeted oligonucleotide therapy paper published in PLOS One Journal
Investors & Partners
Protected: Investor Data
This content is password protected. To view it please enter your password below: